Keymed Biosciences Inc. (02162) released its monthly return on movements in securities for the period ended 30 November 2025. According to the announcement, the company’s authorized share capital remained unchanged at 500,000,000 ordinary shares with a par value of US$0.0001 each, totaling US$50,000. No increases or decreases were recorded during the reporting period.

The issued share capital also remained stable at 298,735,566 ordinary shares, with no movements in treasury shares. No changes were reported for share options, warrants, convertibles, or other agreements to issue shares, and the announcement indicated no updates regarding Hong Kong Depositary Receipts.